S. Michelson

3.4k total citations
80 papers, 2.9k citations indexed

About

S. Michelson is a scholar working on Epidemiology, Immunology and Molecular Biology. According to data from OpenAlex, S. Michelson has authored 80 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Epidemiology, 30 papers in Immunology and 19 papers in Molecular Biology. Recurrent topics in S. Michelson's work include Cytomegalovirus and herpesvirus research (64 papers), Herpesvirus Infections and Treatments (18 papers) and Immune Cell Function and Interaction (13 papers). S. Michelson is often cited by papers focused on Cytomegalovirus and herpesvirus research (64 papers), Herpesvirus Infections and Treatments (18 papers) and Immune Cell Function and Interaction (13 papers). S. Michelson collaborates with scholars based in France, United States and United Kingdom. S. Michelson's co-authors include L. J. M. Laurent, Bahram Bodaghi, Jean‐Louis Virelizier, Donato Zipeto, Octavian Bârzu, J L Virelizier, Olivier Goureau, Patrick S. Beisser, A Topiłko and M.P. Landini and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

S. Michelson

80 papers receiving 2.8k citations

Peers

Countries citing papers authored by S. Michelson

Since Specialization

Citations

This map shows the geographic impact of S. Michelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Michelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Michelson more than expected).

Fields of papers citing papers by S. Michelson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Michelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Michelson. The network helps show where S. Michelson may publish in the future.

Co-authorship network of co-authors of S. Michelson

This figure shows the co-authorship network connecting the top 25 collaborators of S. Michelson. A scholar is included among the top collaborators of S. Michelson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Michelson. S. Michelson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The human cytomegalovirus‐encoded chemokine receptor US28 induces caspase‐dependent apoptosis 2005 ·FEBS Journal ·Olivier Pleskoff, Paola Casarosa, L. Verneuil, (unknown), Patrick S. Beisser, Martine J. Smit, Rob Leurs, Pascal Schneider, S. Michelson, Jean Claude Ameisen	51
2	Use of a lentiviral vector encoding a HCMV-Chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8+ cytotoxic T cells from human peripheral blood cells 2004 ·Human Immunology ·Pierre‐Simon Rohrlich, Sylvain Cardinaud, (unknown), Félix A. Montero‐Julian, Virginie Prod’homme, Hüseyin Firat, J. Davignon, Emmanuelle Perret, (unknown), Antje Necker, S. Michelson, François A. Lemonnier, Pierre Charneau, Christian Davrinche	19
3	Consequences of human cytomegalovirus mimicry 2004 ·Human Immunology ·S. Michelson	35
4	2-chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infections 2002 ·Antiviral Research ·Robert Snoeck, Graciela Andreï, Bahram Bodaghi, Laurence Lagneaux, Dirk Daelemans, Erik De Clercq, Johan Neyts, Dominique Schols, Lieve Naesens, S. Michelson, Dominique Bron, Michaël Otto, Anne Bousseau, (unknown), Christine Le Roy	33
5	High efficient production of Pr55gag virus-like particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype A 2001 ·Antiviral Research ·Luigi Buonaguro, Franco M. Buonaguro, Maria Lina Tornesello, (unknown), Elke Beth‐Giraldo, Ralf Wagner, S. Michelson, Marie‐Christine Prévost, Hans Wolf, G Giraldo	70
6	Human Cytomegalovirus Escape from Immune Detection 1999 ·Intervirology ·S. Michelson	39
7	Role of IFN-γ-Induced Indoleamine 2,3 Dioxygenase and Inducible Nitric Oxide Synthase in the Replication of Human Cytomegalovirus in Retinal Pigment Epithelial Cells 1999 ·The Journal of Immunology ·Bahram Bodaghi, Olivier Goureau, Donato Zipeto, L. J. M. Laurent, Jean‐Louis Virelizier, S. Michelson	138
8	TAR and Sp1-independent transactivation of HIV long terminal repeat by the Tat protein in the presence of human cytomegalovirus IE1/IE2 1997 ·AIDS ·Paola Dal Monte, (unknown), John Sinclair, Jean‐Louis Virelizier, S. Michelson	21
9	Expression of human cytomegalovirus ppUL83 (pp65) in a stable cell line and its association with metaphase chromosomes 1996 ·Journal of General Virology ·Paola Dal Monte, Christine Bessia, Maria Paola Landini, S. Michelson	13
10	Analysis of the Proliferative T Cell Response to Human Cytomegalovirus Major Immediate‐Early Protein (IEl): Phenotype, Frequeney and Variability* 1995 ·Scandinavian Journal of Immunology ·J. Davignon, (unknown), (unknown), S. Michelson, Christian Davrinche	30
11	Induction of Sp1 Phosphorylation and NF-κB-Independent HIV Promoter Domain Activity in T Lymphocytes Stimulated by Okadaic Acid 1995 ·Virology ·Jaromir Vlach, Alphonse Garcı́a, Jean Marc Jacqué, Manuel S. Rodríguez, S. Michelson, Jean‐Louis Virelizier	51
12	Morphological and cytochemical analysis of human cytomegalovirus inoculum: Correlation of free particles in inoculum with counterparts in infected cells 1994 ·Research in Virology ·A Topiłko, S. Michelson	14
13	Multidisciplinary approach to understanding cytomegalovirus disease : proceedings of the Fourth International Cytomegalovirus Workshop: Multidisciplinary Approaches to Understanding CMV Disease, Paris, France, 19-21 April, 1993 1993 ·S. Michelson, Stanley A. Plotkin	2
14	Cytofluorographic analysis of effects of interferons on expression of human cytomegalovirus proteins 1993 ·Journal of Virological Methods ·Sadayoshi Torigoe, Donald E. Campbell, (unknown), S. Michelson, Stuart E. Starr	12
15	Polymerase chain reaction detection of cytomegalovirus genome in renal biopsies 1992 ·Kidney International ·Suzanne Kadereit, S. Michelson, B. Mougenot, Philippe Thibault, P Verroust, F Mignon, R. Colimon, Pierre Ronco	3
16	Induction of an endothelial cell growth factor by human cytomegalovirus infection of fibroblasts 1991 ·Journal of General Virology ·José Alcamı́, Tereza Bârzu, S. Michelson	43
17	Heparin‐derived oligosaccharides: Affinity for acidic fibroblast growth factor and effect on its growth‐promoting activity for human endothelial cells 1989 ·Journal of Cellular Physiology ·Tereza Bârzu, Jean‐Claude Lormeau, Maurice Petitou, S. Michelson, J Choay	53
18	The pathogenesis and prevention of human cytomegalovirus infection 1984 ·The Pediatric Infectious Disease Journal ·Stanley A. Plotkin, S. Michelson, Charles A. Alford, Stuart E. Starr, Paul D. Parkman, Joseph S. Pagano, Fred Rapp	7
19	Simple and fast purification of Escherichia coli adenylate kinase 1983 ·FEBS Letters ·Octavian Bârzu, S. Michelson	58
20	Latent infection of mouse cells with human cytomegalovirus. 1976 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·István Boldogh, Éva Gönczöl, (unknown), (unknown), S. Michelson	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact